Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Other Gross PP&E Adjustments (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with -$552695.0 as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 12.29% to -$552695.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$552695.0 through Dec 2025, up 12.29% year-over-year, with the annual reading at -$552695.0 for FY2025, 12.29% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$552695.0 at bioAffinity Technologies, down from $263095.0 in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $384113.0 in Q1 2023, with the low at -$787732.0 in Q4 2023.
  • Average Other Gross PP&E Adjustments over 4 years is -$214929.5, with a median of -$426393.0 recorded in 2023.
  • The sharpest move saw Other Gross PP&E Adjustments plummeted 12102.62% in 2023, then surged 165.85% in 2025.
  • Over 4 years, Other Gross PP&E Adjustments stood at $6563.0 in 2022, then tumbled by 12102.62% to -$787732.0 in 2023, then increased by 20.01% to -$630106.0 in 2024, then grew by 12.29% to -$552695.0 in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$552695.0, $263095.0, and $364987.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.